Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Peptide Therapeutics can be widely used to treat cancer, metabolic disorders, and cardiovascular diseases. When the level of endogenous peptide tends to decline, peptide drugs will be used as an alternative therapy to supplement peptide hormones. Clinical global authorities in the United States, Europe and Japan have approved 60 peptide drugs.
During the forecast period, the Peptide Therapeutics market will achieve significant market growth, culminating in a compound annual growth rate of 8.4%. Cell-penetrating peptides will bring a broader prospect for the Peptide Therapeutics market. Cell-penetrating peptides, known as ideal transporters, assist therapeutic drugs in a nontoxic and simple manner, including proteins, oligonucleotides, nanoparticles, and so on.
The increase in the incidence rate of cancer and metabolic diseases such as osteoporosis, obesity and diabetes is a major factor driving the growth of Peptide Therapeutics market during the forecast period. In addition, the growing population base affected and the prevalence of targeted diseases in low-income countries will greatly stimulate the market demand for Peptide Therapeutics.
The report details the trend, potential and market size of Peptide Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Peptide Therapeuticsmarket, defines the market attractiveness level of Peptide Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Peptide Therapeutics industry, describes the types of Peptide Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Peptide Therapeutics market and the development prospects and opportunities of Peptide Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Peptide Therapeutics market in Chapter 13.
By Player:
Eli Lilly
Novartis
AstraZeneca
Novo Nordisk
Merck
AbbVie
Ipsen
Roche
Takeda
J & J
Allergan
Shire
Sanofi
The Medicines
Teva
Ferring
By Type:
Injection
Oral
Other
By End-User:
Cancer
Metabolic Disorders
Central Nervous System
Cardiovascular Disorder
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Peptide Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Peptide Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Peptide Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Peptide Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Peptide Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Peptide Therapeutics Consumption (2017-2022)
-
7.2 United States Peptide Therapeutics Consumption (2017-2022)
-
7.3 Europe Peptide Therapeutics Consumption (2017-2022)
-
7.4 China Peptide Therapeutics Consumption (2017-2022)
-
7.5 Japan Peptide Therapeutics Consumption (2017-2022)
-
7.6 India Peptide Therapeutics Consumption (2017-2022)
-
7.7 South Korea Peptide Therapeutics Consumption (2017-2022)
8 Region and Country-wise Peptide Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Peptide Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Peptide Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Peptide Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Peptide Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Peptide Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Peptide Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Peptide Therapeutics Consumption Forecast (2022-2028)
9 Global Peptide Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Peptide Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Injection Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Peptide Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Metabolic Disorders Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Central Nervous System Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Cardiovascular Disorder Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Peptide Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Peptide Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Peptide Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Metabolic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Central Nervous System Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Cardiovascular Disorder Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Peptide Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Peptide Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Peptide Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Peptide Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Peptide Therapeutics Market Competitive Analysis
-
14.1 Eli Lilly
-
14.1.1 Eli Lilly Company Details
-
14.1.2 Eli Lilly Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Eli Lilly Peptide Therapeutics Product and Service
-
14.2 Novartis
-
14.2.1 Novartis Company Details
-
14.2.2 Novartis Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novartis Peptide Therapeutics Product and Service
-
14.3 AstraZeneca
-
14.3.1 AstraZeneca Company Details
-
14.3.2 AstraZeneca Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 AstraZeneca Peptide Therapeutics Product and Service
-
14.4 Novo Nordisk
-
14.4.1 Novo Nordisk Company Details
-
14.4.2 Novo Nordisk Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novo Nordisk Peptide Therapeutics Product and Service
-
14.5 Merck
-
14.5.1 Merck Company Details
-
14.5.2 Merck Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Merck Peptide Therapeutics Product and Service
-
14.6 AbbVie
-
14.6.1 AbbVie Company Details
-
14.6.2 AbbVie Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 AbbVie Peptide Therapeutics Product and Service
-
14.7 Ipsen
-
14.7.1 Ipsen Company Details
-
14.7.2 Ipsen Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Ipsen Peptide Therapeutics Product and Service
-
14.8 Roche
-
14.8.1 Roche Company Details
-
14.8.2 Roche Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Roche Peptide Therapeutics Product and Service
-
14.9 Takeda
-
14.9.1 Takeda Company Details
-
14.9.2 Takeda Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Takeda Peptide Therapeutics Product and Service
-
14.10 J & J
-
14.10.1 J & J Company Details
-
14.10.2 J & J Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 J & J Peptide Therapeutics Product and Service
-
14.11 Allergan
-
14.11.1 Allergan Company Details
-
14.11.2 Allergan Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Allergan Peptide Therapeutics Product and Service
-
14.12 Shire
-
14.12.1 Shire Company Details
-
14.12.2 Shire Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Shire Peptide Therapeutics Product and Service
-
14.13 Sanofi
-
14.13.1 Sanofi Company Details
-
14.13.2 Sanofi Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Sanofi Peptide Therapeutics Product and Service
-
14.14 The Medicines
-
14.14.1 The Medicines Company Details
-
14.14.2 The Medicines Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 The Medicines Peptide Therapeutics Product and Service
-
14.15 Teva
-
14.15.1 Teva Company Details
-
14.15.2 Teva Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Teva Peptide Therapeutics Product and Service
-
14.16 Ferring
-
14.16.1 Ferring Company Details
-
14.16.2 Ferring Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Ferring Peptide Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Peptide Therapeutics
-
Figure Peptide Therapeutics Picture
-
Table Global Peptide Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Peptide Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Peptide Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Peptide Therapeutics Consumption by Country (2017-2022)
-
Figure United States Peptide Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Peptide Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Peptide Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Peptide Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Peptide Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Peptide Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Peptide Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Peptide Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Peptide Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Peptide Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Peptide Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Peptide Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Peptide Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Metabolic Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Central Nervous System Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Disorder Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Metabolic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Central Nervous System Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Peptide Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Peptide Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Peptide Therapeutics Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Peptide Therapeutics Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Peptide Therapeutics Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Peptide Therapeutics Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Peptide Therapeutics Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Peptide Therapeutics Product and Service
-
Table Ipsen (Foundation Year, Company Profile and etc.)
-
Table Ipsen Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ipsen Peptide Therapeutics Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Peptide Therapeutics Product and Service
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Peptide Therapeutics Product and Service
-
Table J & J (Foundation Year, Company Profile and etc.)
-
Table J & J Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table J & J Peptide Therapeutics Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Peptide Therapeutics Product and Service
-
Table Shire (Foundation Year, Company Profile and etc.)
-
Table Shire Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Peptide Therapeutics Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Peptide Therapeutics Product and Service
-
Table The Medicines (Foundation Year, Company Profile and etc.)
-
Table The Medicines Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table The Medicines Peptide Therapeutics Product and Service
-
Table Teva (Foundation Year, Company Profile and etc.)
-
Table Teva Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Peptide Therapeutics Product and Service
-
Table Ferring (Foundation Year, Company Profile and etc.)
-
Table Ferring Peptide Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ferring Peptide Therapeutics Product and Service
-
